“For me, this is one of the great honors of my research career,” says Dr. Ronald DePinho, who in 2009 won the prestigious Szent-Györgyi Prize for Progress in Cancer Research—and who has […]
Ronald DePinho: The Age of Cancer
Mark It Down: The Development of Better Ovarian Cancer Biomarkers
NFCR Writer David Perry – September 13, 2018 “The trouble with ultrasound is that it doesn’t detect many ovarian cancers early,” says Robert Bast, M.D., Vice President for Translational Research at MD […]
Pediatric Cancer Drug Has 93 Percent Effectiveness
September 5, 2018 A new cancer drug, larotrectinib, has in a very early clinical trial been shown to have a 93% (14/15) effectiveness rate for pediatric cancers; that is to say, for […]
Early Days, But New Compound May Prevent Metastasis
“For the vast majority of cancer—breast, prostate, lung, colon and others—if it is detected early when it is a little lump in that organ and it has not spread, you will live. […]
NCI-Led Research Team Develops Predictor for Immunotherapy Response in Melanoma
NCI Press Release August 20, 2018 In a new study, researchers developed a gene expression predictor that can indicate whether melanoma in a specific patient is likely to respond to treatment with […]
Oxidative Stress: The Role of Micronutrients in Battling Cancer
NFCR Press Release NFCR Writer David Perry August 17, 2018 NFCR Breakthroughs The good news is that cocoa is good for you. The seeds of Theobroma cacao are packed with flavonoids, organic […]
Liquid Biopsy May Predict Risk of Breast Cancer Returning Years Later
NCI Press Release August 15, 2018 Women who had cancer cells detected in their blood 5 years after a breast cancer diagnosis were 13 times more likely to have their cancer return […]
Breakthrough in Ewing Sarcoma Research
NFCR Press Release NFCR Writer David Perry July 21, 2018 In both mouse and culture-dish experiments, researchers at the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center found that a new line of […]
